PANACEA BIOTECH: ICMR Update on Dengue Vaccine & New Medical Device
Dengue Vaccine:
Developed by Panacea Biotec; Phase 3 trials underway with ICMR.
80% of 10,500 participants enrolled.
Results expected in ~2 years, potentially leading to market launch.
New Device:
Handheld infrared tool approved by DCGI & CDSCO.
Serves as an easy alternative to CT scans for detecting brain injury/bleeding.
No comments:
Post a Comment